Tumor associated carbonic anhydrase inhibitors: Rational approaches, design strategies, structure activity relationship and mechanistic insights
Sridhar Goud Nerella(National Institutes of Health), Claudiu T. Supuran(University of Florence), Pavitra S. Thacker(National Institute of Pharmaceutical Education and Research), Mohammed Arifuddin(Maulana Azad National Urdu University)
Cited by 25
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5k
Interfering with pH regulation in tumours as a therapeutic strategy
|Nature Reviews Drug Discovery|2011|1.5k
How many carbonic anhydrase inhibition mechanisms exist?
|Journal of Enzyme Inhibition and Medicinal Chemistry|2015|724
Structure-based drug discovery of carbonic anhydrase inhibitors
|Journal of Enzyme Inhibition and Medicinal Chemistry|2012|608
Rosmarinic acid inhibits some metabolic enzymes including glutathione<i>S</i>-transferase, lactoperoxidase, acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase isoenzymes
|Journal of Enzyme Inhibition and Medicinal Chemistry|2016|228